γ-Secretase
Pharmacological Assessment of γ Secretase Activity from Rodent and Human Brain
13
An exo-cell assay for examining real-time γ-secretase activity and inhibition
9
γ Secretase inhibitor–resistant glioblastoma stem cells require RBPJ to propagate
5
Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer’s disease
7
Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator
15
NSAIDs and enantiomers of flurbiprofen target γ secretase and lower Aβ42 in vivo
11
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment
10
Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
10
A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
7
ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity
19
Super-resolution microscopy reveals γ-secretase at both sides of the neuronal synapse
12
Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel γ-secretase substrates
11
The cytotoxicity of γ secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ secretase inhibition
12
QSAR STUDIES & DESIGNING OF POTENT HETEROCYCLIC COMPOUNDS AS γ SECRETASE INHIBITORS
14
Papillomavirus Infection Requires γ Secretase
10
Vesicular Trafficking of Incoming Human Papillomavirus 16 to the Golgi Apparatus and Endoplasmic Reticulum Requires γ Secretase Activity
11
The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase
22
Presenilins and the γ-secretase: still a complex problem
6
Biological function of Presenilin and its role in AD pathogenesis
13
The impact of neuronal Notch-1/JNK pathway on intracerebral hemorrhage-induced neuronal injury of rat model
9